Long COVID in Patients with Multiple Sclerosis Treated with Rituximab: A Report of Two Cases.

Tanaffos · 2025 · PMC13098001 · PMID 42022303

Europe PMC

hedged sentence

—

closest p

—

boldest claim

The sentences

a decreasing trendno p-value reported

Some studies have shown a decreasing trend in immunoglobulin levels, specifically IgG, during rituximab treatment in patients with MS.

also in 47,180 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.